BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190314
DTEND;VALUE=DATE:20190316
DTSTAMP:20260526T030037
CREATED:20190115T144816Z
LAST-MODIFIED:20190115T144816Z
UID:18893-1552521600-1552694399@www.afssi.fr
SUMMARY:3rd Annual Next Gen MarketsandMarkets Immuno-Oncology Congress
DESCRIPTION:Description:\nOver the past several years\, many immuno-oncology modalities have emerged. These modalities\, which include checkpoint inhibition\, adoptive T-cell therapy (ACT)\, and cancer vaccines\, are often designed to evade immune responses. This is a rapidly growing therapeutic field that embraces the concept of modulating the immune system to recognize tumor cells and target them for destruction. Our Next Gen Immuno-Oncology Congress from past 2 years had gathered the professionals across the globe to deliver such latest developments. \nHaving completed two extremely successful editions\, MarketsandMarkets’ is coming up with “3rd Annual Next-Gen Immuno-Oncology Congress” gathering the academicians\, researchers and scientists from research institutes pharmaceutical\, biopharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s\, Bispecific Antibodies\, Immune Checkpoint Inhibitors and Adoptive Cellular Therapy. \nTickets:\nTickets
URL:https://www.afssi.fr/event/3rd-annual-next-gen-marketsandmarkets-immuno-oncology-congress/
LOCATION:Londres\, United Kingdom
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/png:https://www.afssi.fr/wp-content/uploads/2019/01/MarketsandMarkets-Immuno-Oncology-congress.fw_.png
END:VEVENT
END:VCALENDAR